A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury

Completed · Phase 1/Phase 2

Conditions studied: Respiratory Distress Syndrome, Adult, Acute Lung Injury

In brief

The purpose of this study is to determine whether sivelestat will reduce the amount of time a patient must spend on a ventilator and/or increase the chance of survival of patients with acute lung injury.

Key facts

Study ID

NCT00036062

Run by

Eli Lilly and Company

People needed

600

Starts

2001-08-01

Expected to finish

2002-12-01

Last updated by the study team

2006-07-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• show evidence of acute lung injury
• be on mechanical ventilation

You may not qualify if…

• have undergone certain organ transplants
• have severe underlying medical problems
• be unlikely to survive
• be pregnant or breast-feeding

Where it is running

• Study site — Phoenix, Arizona, United States
• Study site — Tucson, Arizona, United States
• Study site — Orange, California, United States
• Study site — Sacramento, California, United States
• Study site — San Diego, California, United States
• Study site — Denver, Colorado, United States
• Study site — Englewood, Colorado, United States
• Study site — New Haven, Connecticut, United States
• Study site — Washington D.C., District of Columbia, United States
• Study site — Bay Pines, Florida, United States
• Study site — Clearwater, Florida, United States
• Study site — Fort Lauderdale, Florida, United States
• Study site — Augusta, Georgia, United States
• Study site — Austell, Georgia, United States
• Study site — Chicago, Illinois, United States
• Study site — Elk Grove Village, Illinois, United States
• Study site — Maywood, Illinois, United States
• Study site — North Chicago, Illinois, United States
• Study site — Indianapolis, Indiana, United States
• Study site — Des Moines, Iowa, United States
• Study site — Kansas City, Kansas, United States
• Study site — Lexington, Kentucky, United States
• Study site — Louisville, Kentucky, United States
• Study site — Baton Rouge, Louisiana, United States
• Study site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.